Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001290622 | SCV001478733 | likely benign | not specified | 2021-01-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001422838 | SCV001625396 | likely benign | RASopathy | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001587321 | SCV001814629 | likely benign | not provided | 2021-05-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327627 | SCV002633895 | likely benign | Cardiovascular phenotype | 2019-08-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |